Use of propranolol for treatment of hemangiomas in PHACE syndrome

Journal of Perinatology

Volumn 31, Issue 11, 2011, Pages 739-741

  Solomon, T ^a   Ninnis, J ^a   Deming, D ^a   Merritt, T A ^a   Hopper, A ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

facial hemangiomas; infantile hemangiomas; PHACE syndrome; propranolol; segmental hemangiomas

Indexed keywords

CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; LUNG SURFACTANT; PREDNISONE; PROPRANOLOL; VINCRISTINE;

ARTICLE; ASSISTED VENTILATION; CAPILLARY HEMANGIOMA; CASE REPORT; CEREBELLUM HYPOPLASIA; CORPUS CALLOSUM AGENESIS; ECHOCARDIOGRAPHY; ENTERIC FEEDING; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HOSPITAL DISCHARGE; HUMAN; INFANT; NASOGASTRIC TUBE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PHACE SYNDROME; PHAKOMATOSIS; POSITIVE END EXPIRATORY PRESSURE; POSTERIOR FOSSA MALFORMATION HEMANGIOMA ARTERIAL ANOMALY CARDIAC ANOMALY EYE ANOMALY SYNDROME; REMISSION; VISUAL SYSTEM EXAMINATION;

ABNORMALITIES, MULTIPLE; ADRENERGIC BETA-ANTAGONISTS; FACIAL NEOPLASMS; FEMALE; HEMANGIOMA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROPRANOLOL; SKIN NEOPLASMS; SYNDROME;

EID: 80455168214     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.28     Document Type: Article

References (13)

1. Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124: 1447-1456.
2. Léauté-Labréze CA. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358(24): 2649-2651.
3. Sans V, Léauté-Labréze C. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009; 124: E423-e431.
4. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986; 3(4): 331-332.
5. Metry DW, Haggstrom AN, Drolet BA, Baselga E, Chamlin S, Garzon M et al. A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140(9): 975-986.
6. Haggstrom AN, Garzon MC, Baselga E, Chamlin SL, Frieden IJ, Holland K et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126: E418-e426.
7. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132: 307-311.
8. Poetke M, Frommeld T, Berlien HP. PHACE syndrome: New views on diagnostic criteria. Eur J Pediatr Surg 2002; 12: 366-374.
9. Metry DW, Dowd CF, Barkovich AJ, Frieden IJ. The many faces of PHACE syndrome. J Pediatr 2001; 139: 117-123.
10. Bennett ML, Fleischer Jr. AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation. Arch Dermatol 2001; 137: 1208-1213.
11. Lawley LP. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol 2009; 26(5): 610-614.
12. Mousa W, Kues K, Haas E, Lauerer P, Pavlakovic H, Schön MP et al. Successful treatment of hemagioma with propranolol. J Dtsch Dermatol Ges 2010; 8(3): 184-186.
13. http://www.clinicaltrials.gov